A research team has developed an innovative screening test. With a blood sample from the expectant mother, they can scrutinize all the genes in the fetus. The findings indicate that the new test, named desNIPT, has demonstrated effectiveness in identifying alterations in fetal genes — a leading factor in severe congenital diseases.
